biotech investing Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights
biotech investing BriaCell to Present Positive Clinical Data for Bria-IMT and Preclinical Data for Next Generation Bria-OTS+ Personalized Immunotherapy at the 2026 AACR Conference
biotech investing argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
biotech investing argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
biotech investing Cizzle Brands Corporation Launches SnakStars Sport Bites: A Nut-Free, High-Protein, High-Fibre Snack Designed for Active Kids
biotech investing argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
biotech investing BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
EnerCom Announces Initial List of Presenting Companies for the 31st Annual Energy Investment Conference to be held August 17-19, 2026, in Denver, Colorado
